• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺动脉高压与系统性硬化症相关肺动脉高压患者右心室肌原纤维功能差异。

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.

机构信息

Divisions of Cardiology (S.H., K.M.K.-S., M.M., D.A.K.)

Divisions of Cardiology (S.H., K.M.K.-S., M.M., D.A.K.).

出版信息

Circulation. 2018 May 29;137(22):2360-2370. doi: 10.1161/CIRCULATIONAHA.117.033147. Epub 2018 Jan 19.

DOI:10.1161/CIRCULATIONAHA.117.033147
PMID:29352073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5976528/
Abstract

BACKGROUND

Patients with systemic sclerosis (SSc)-associated pulmonary arterial hypertension (PAH) have a far worse prognosis than those with idiopathic PAH (IPAH). In the intact heart, SSc-PAH exhibits depressed rest and reserve right ventricular (RV) contractility compared with IPAH. We tested whether this disparity involves underlying differences in myofilament function.

METHODS

Cardiac myocytes were isolated from RV septal endomyocardial biopsies from patients with SSc-PAH, IPAH, or SSc with exertional dyspnea but no resting PAH (SSc-d); control RV septal tissue was obtained from nondiseased donor hearts (6-7 per group). Isolated myocyte passive length-tension and developed tension-calcium relationships were determined and correlated with in vivo RV function and reserve. RV septal fibrosis was also examined.

RESULTS

Myocyte passive stiffness from length-tension relations was similarly increased in IPAH and SSc-PAH compared with control, although SSc-PAH biopsies had more interstitial fibrosis. More striking disparities were found between active force-calcium relations. Compared with controls, maximal calcium-activated force (F) was 28% higher in IPAH but 37% lower in SSc-PAH. F in SSc-d was intermediate between control and SSc-PAH. The calcium concentration required for half-maximal force (EC) was similar between control, IPAH, and SSc-d but lower in SSc-PAH. This disparity disappeared in myocytes incubated with the active catalytic subunit of protein kinase A. Myocyte F directly correlated with in vivo RV contractility assessed by end-systolic elastance ( =0.46, =0.002) and change in end-systolic elastance with exercise ( =0.49, =0.008) and was inversely related with exercise-induced chamber dilation ( =0.63, <0.002), which also was a marker of depressed contractile reserve.

CONCLUSIONS

A primary defect in human SSc-PAH resides in depressed sarcomere function, whereas this is enhanced in IPAH. These disparities correlate with in vivo RV contractility and contractile reserve and are consistent with worse clinical outcomes in SSc-PAH. The existence of sarcomere disease before the development of resting PAH in patients with SSc-d suggests that earlier identification and intervention may prove useful.

摘要

背景

与特发性肺动脉高压(IPAH)相比,系统性硬化症(SSc)相关肺动脉高压(PAH)患者的预后要差得多。在完整的心脏中,与 IPAH 相比,SSc-PAH 表现出静息和储备右心室(RV)收缩力降低。我们检测了这种差异是否涉及肌丝功能的潜在差异。

方法

从 SSc-PAH、IPAH 或 SSc 伴运动性呼吸困难但无静息性 PAH(SSc-d)患者的 RV 间隔心内膜心肌活检中分离心肌细胞。对照 RV 间隔组织取自非病变供心(每组 6-7 个)。确定分离的心肌细胞被动长度-张力和发育张力-钙关系,并与体内 RV 功能和储备相关。还检查了 RV 间隔纤维化。

结果

与对照组相比,IPAH 和 SSc-PAH 的肌细胞被动刚度与长度-张力关系相似增加,尽管 SSc-PAH 活检中存在更多的间质纤维化。在主动力-钙关系之间发现了更显著的差异。与对照组相比,IPAH 的最大钙激活力(F)高 28%,而 SSc-PAH 的 F 低 37%。SSc-d 的 F 介于对照组和 SSc-PAH 之间。一半最大力(EC)所需的钙浓度在对照组、IPAH 和 SSc-d 之间相似,但在 SSc-PAH 中较低。这种差异在用蛋白激酶 A 的活性催化亚单位孵育的心肌细胞中消失。肌细胞 F 与通过收缩末期弹性评估的体内 RV 收缩性直接相关( =0.46,=0.002),与运动时收缩末期弹性的变化相关( =0.49,=0.008),与运动诱导的腔扩张呈负相关( =0.63,<0.002),这也是收缩储备降低的标志物。

结论

人类 SSc-PAH 的主要缺陷在于肌节功能降低,而 IPAH 则增强。这些差异与体内 RV 收缩性和收缩储备相关,与 SSc-PAH 的临床预后较差一致。SSc-d 患者在发生静息性 PAH 之前存在肌节疾病,这表明早期识别和干预可能有用。

相似文献

1
Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.特发性肺动脉高压与系统性硬化症相关肺动脉高压患者右心室肌原纤维功能差异。
Circulation. 2018 May 29;137(22):2360-2370. doi: 10.1161/CIRCULATIONAHA.117.033147. Epub 2018 Jan 19.
2
Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.肺动脉高压患者的右心室功能储备
Circulation. 2016 Jun 14;133(24):2413-22. doi: 10.1161/CIRCULATIONAHA.116.022082. Epub 2016 May 11.
3
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.系统性硬化症相关肺动脉高压与特发性肺动脉高压治疗中右心室功能变化的差异。
Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC.
4
Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.系统性硬皮病相关肺动脉高压的右心功能障碍。
Circ Heart Fail. 2013 Sep 1;6(5):953-63. doi: 10.1161/CIRCHEARTFAILURE.112.000008.
5
Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.特发性和系统性硬化症相关肺动脉高压:人口统计学、血流动力学和 MRI 特征及预后的比较。
Chest. 2017 Jul;152(1):92-102. doi: 10.1016/j.chest.2017.02.010. Epub 2017 Feb 20.
6
Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.特发性肺动脉高压和系统性硬皮病相关肺动脉高压患者的甲襞毛细血管变化。
Microvasc Res. 2017 Nov;114:46-51. doi: 10.1016/j.mvr.2017.06.005. Epub 2017 Jun 12.
7
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension.系统性硬化症相关性和特发性肺动脉高压中的右心室收缩功能
Eur Respir J. 2008 Jun;31(6):1160-6. doi: 10.1183/09031936.00135407. Epub 2008 Jan 23.
8
Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.甲襞毛细血管密度与系统性硬化症中肺动脉高压的存在及严重程度相关。
Ann Rheum Dis. 2009 Feb;68(2):191-5. doi: 10.1136/ard.2007.087353. Epub 2008 Mar 28.
9
Myocardial adaptation and exercise performance in patients with pulmonary arterial hypertension assessed with patient-specific computer simulations.采用个体化计算机模拟评估肺动脉高压患者的心肌适应性和运动表现。
Am J Physiol Heart Circ Physiol. 2021 Nov 1;321(5):H865-H880. doi: 10.1152/ajpheart.00442.2021. Epub 2021 Aug 27.
10
Exercise testing can unmask right ventricular dysfunction in systemic sclerosis patients with normal resting pulmonary artery pressure.运动试验可揭示静息肺动脉压正常的系统性硬化症患者的右心室功能障碍。
Int J Cardiol. 2016 Feb 1;204:179-86. doi: 10.1016/j.ijcard.2015.11.186. Epub 2015 Nov 28.

引用本文的文献

1
An Integrated Pressure-Volume Loop and Pulmonary Artery Catheter.集成压力-容积环与肺动脉导管
JACC Basic Transl Sci. 2025 Jul 29;10(8):101326. doi: 10.1016/j.jacbts.2025.101326.
2
Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension.肺部单细胞转录组学揭示了硬皮病相关与特发性肺动脉高压不同的病理生物学及精准靶向治疗机会。
Circ Genom Precis Med. 2025 Jul 21:e004936. doi: 10.1161/CIRCGEN.124.004936.
3
Long-term prognostic value of native myocardial tissue relaxation parameters (T1, T2, and T1ρ) in patients with precapillary pulmonary hypertension.

本文引用的文献

1
An official European Respiratory Society statement: pulmonary haemodynamics during exercise.欧洲呼吸学会官方声明:运动期间的肺血液动力学。
Eur Respir J. 2017 Nov 22;50(5). doi: 10.1183/13993003.00578-2017. Print 2017 Nov.
2
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.系统性硬化症相关肺动脉高压与特发性肺动脉高压治疗中右心室功能变化的差异。
Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC.
3
Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
毛细血管前性肺动脉高压患者心肌组织固有弛豫参数(T1、T2和T1ρ)的长期预后价值
Int J Cardiovasc Imaging. 2025 Jul 5. doi: 10.1007/s10554-025-03451-5.
4
ATP directly modulates thick filament structure and function in porcine myocardium.三磷酸腺苷直接调节猪心肌中粗肌丝的结构和功能。
Biophys J. 2025 Jun 28. doi: 10.1016/j.bpj.2025.06.037.
5
A Word of Caution-Potential Limitations of Pulmonary Artery Pressure Monitoring in Detecting Congestion Caused by Right-Sided Heart Failure.注意事项——肺动脉压监测在检测右心衰竭所致充血方面的潜在局限性。
Biomedicines. 2025 Jun 14;13(6):1469. doi: 10.3390/biomedicines13061469.
6
Molecular Pathogenesis of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Narrative Review.结缔组织病相关肺动脉高压的分子发病机制:一项叙述性综述
Biomolecules. 2025 May 27;15(6):772. doi: 10.3390/biom15060772.
7
Pulmonary vascular dysfunction in systemic sclerosis.系统性硬化症中的肺血管功能障碍
JHLT Open. 2023 Nov 19;3:100024. doi: 10.1016/j.jhlto.2023.100024. eCollection 2024 Feb.
8
The effect of hematopoietic stem cell transplantation on cardiac mechanics in systemic sclerosis.造血干细胞移植对系统性硬化症心脏力学的影响。
Int J Cardiovasc Imaging. 2025 May;41(5):879-887. doi: 10.1007/s10554-025-03365-2. Epub 2025 Feb 26.
9
Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications.系统性硬化症中的心肌病:最新进展与临床意义
Curr Cardiol Rep. 2025 Jan 4;27(1):3. doi: 10.1007/s11886-024-02164-w.
10
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series).肺血管疾病的精准医学:未来已来(2023年格罗弗会议系列)
Pulm Circ. 2025 Jan 2;15(1):e70027. doi: 10.1002/pul2.70027. eCollection 2025 Jan.
特发性和系统性硬化症相关肺动脉高压:人口统计学、血流动力学和 MRI 特征及预后的比较。
Chest. 2017 Jul;152(1):92-102. doi: 10.1016/j.chest.2017.02.010. Epub 2017 Feb 20.
4
Unique Abnormalities in Right Ventricular Longitudinal Strain in Systemic Sclerosis Patients.系统性硬化症患者右心室纵向应变的独特异常
Circ Cardiovasc Imaging. 2016 Jun;9(6). doi: 10.1161/CIRCIMAGING.115.003792. Epub 2016 Jun 7.
5
Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.肺动脉高压患者的右心室功能储备
Circulation. 2016 Jun 14;133(24):2413-22. doi: 10.1161/CIRCULATIONAHA.116.022082. Epub 2016 May 11.
6
Pacemaker-induced transient asynchrony suppresses heart failure progression.起搏器诱导的短暂不同步可抑制心力衰竭进展。
Sci Transl Med. 2015 Dec 23;7(319):319ra207. doi: 10.1126/scitranslmed.aad2899.
7
Criteria for diagnosis of exercise pulmonary hypertension.运动性肺动脉高压的诊断标准。
Eur Respir J. 2015 Sep;46(3):728-37. doi: 10.1183/09031936.00021915. Epub 2015 May 28.
8
Targeting the sarcomere to correct muscle function.靶向肌节以纠正肌肉功能。
Nat Rev Drug Discov. 2015 May;14(5):313-28. doi: 10.1038/nrd4554. Epub 2015 Apr 17.
9
The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.肺动脉高压患者的右心室:右心衰竭中的代谢紊乱、血管生成和肾上腺素能信号传导。
Circ Res. 2014 Jun 20;115(1):176-88. doi: 10.1161/CIRCRESAHA.113.301129.
10
Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension.导致肺动脉高压时右心室心肌细胞舒张功能障碍的蛋白质变化。
J Am Heart Assoc. 2014 Jun 3;3(3):e000716. doi: 10.1161/JAHA.113.000716.